Document: NUREG-0800
Document ID: 5019fa2b-7710-4c15-814b-3c97de8c0a60
Document Type: srp
Title: FITNESS FOR DUTY − OPERATIONAL PROGRAM
Source: NUREG-0800
Source URL: https://www.nrc.gov/docs/ML1132/ML113250541.pdf
Revision Date: 2023-06
Chapter: 13
Section ID: 13.7.1
CFR Part: 
CFR Title: 

Content:
ted to, procedures for implementing the drug testing program and the BOP, for determining fitness for duty, and for protecting the privacy of the 13.7.1-9 Draft Revision 0 – June 2013 individual. If applicable, the applicant should assess and describe how it would integrate its construction site staff with the operational unit FFD program staff to provide reasonable assurance of the continued effectiveness of the FFD program. The reviewer should ensure that the applicant describes how the FFD program supports the granting of authorization to individuals. The description should describe the requirements for initial authorization, authorization update, authorization reinstatement, and authorization with potentially disqualifying FFD information. Training, 10 CFR 26.29 and 10 CFR 26.203(c) The applicant’s description of its FFD program must describe the FFD training program. The description must include how the applicant’s training program would be implemented as required by 10 CFR 52.79(a)(44). This training program must encompass the knowledge and abilities set forth in 10 CFR 26.29(a), “Training” and 10 CFR 26.203(c), “Training and examinations.” The training program description must include a description of the comprehensive examination process required by 10 CFR 26.29(b). The training program description must include initial training requirements and refresher training requirements pursuant to 10 CFR 26.29(c). Refresher training must be completed on a nominal 12-month frequency, or more frequently where the need is indicated. Drug and Alcohol Testing, 10 CFR 26.31, 26.127, and 26.153 The applicant must describe the process and procedures required for drug and alcohol testing. The applicant should include the elements described below: The applicant should identify whether it intends to utilize an LTF. The applicant should also identify its proposed primary and secondary HHS-certified laboratories and blind performance test specimen provider. The